Xeroderma pigmentosum
- Type
- Disease
- Group
- Disorder
- Inheritance
- Autosomal recessive
- Age of onset
- All ages
- Status
- active
Xeroderma pigmentosum (XP) is a rare genodermatosis characterized by extreme sensitivity to ultraviolet (UV)-induced changes in the skin and eyes, and multiple skin cancers. It is subdivided into 8 complementation groups, according to the affected gene: classical XP (XPA to XPG) and XP variant (XPV).
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | Xeroderma pigmentosum | |
| fr | Xeroderma pigmentosum | |
| de | Xeroderma pigmentosum | XP |
| es | Xeroderma pigmentoso | |
| it | Xeroderma pigmentoso | XP |
| nl | Xeroderma pigmentosum | |
| pt | Xeroderma pigmentoso | |
| pl | Skóra pergaminowa | XP |
| cs | Xeroderma pigmentosum | XP |
| uk | Пігментна ксеродерма | |
| zh | 着色性干皮病 | |
| tr | Kseroderma pigmentozum |
Definition in:
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| OMIM | 278700 | BTNT | validated | |
| OMIM | 278720 | BTNT | validated | |
| OMIM | 278730 | BTNT | validated | |
| OMIM | 278740 | BTNT | validated | |
| OMIM | 278760 | BTNT | validated | |
| OMIM | 278780 | BTNT | validated | |
| OMIM | 610651 | BTNT | validated | |
| ICD-10 | Q82.1 | E | specific | validated |
| ICD-11 | LD27.1 | E | specific | validated |
| MONDO | 0019600 | E | validated | |
| MeSH | D014983 | E | validated | |
| UMLS | C0043346 | E | validated | |
| GARD | 7910 | E | validated | |
| MedDRA | 10048220 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (13):
- ORPHA:98097Autosomal recessive cerebellar ataxia due to a DNA repair defect
rare genetic diseases; rare neurological diseases - ORPHA:183490Genetic photodermatosis
rare genetic diseases - ORPHA:363245Genetic progeroid syndrome
rare genetic diseases - ORPHA:183422Polymalformative genetic syndrome with increased risk of developing cancer
rare genetic diseases; rare neoplastic diseases - ORPHA:139033Progeroid syndrome
rare developmental anomalies during embryogenesis - ORPHA:139027Rare developmental defect with skin/mucosae involvement
rare developmental anomalies during embryogenesis; rare genetic diseases - ORPHA:519270Rare disorder with entropion
rare developmental anomalies during embryogenesis; rare ophthalmic disorders - ORPHA:522530Rare genetic disorder with entropion
rare genetic diseases - ORPHA:79390Rare photodermatosis
rare skin diseases - ORPHA:611314Rare syndromic intellectual disability without multiple congenital anomalies/dysmorphic syndrome
rare genetic diseases; rare neurological diseases - ORPHA:98571Secondary ectropion
rare developmental anomalies during embryogenesis; rare genetic diseases; rare ophthalmic disorders - ORPHA:98641Syndromic cataract
rare ophthalmic disorders - ORPHA:522548Syndromic genetic cataract
rare genetic diseases
No children.
Codes that Orphanet moved or referred to this one:
- ORPHA:1569De Sanctis-Cacchione syndrome moved to · inactive
- ORPHA:276249OBSOLETE: Xeroderma pigmentosum complementation group A referred to · inactive
- ORPHA:276252OBSOLETE: Xeroderma pigmentosum complementation group B referred to · inactive
- ORPHA:276255OBSOLETE: Xeroderma pigmentosum complementation group C referred to · inactive
- ORPHA:276258OBSOLETE: Xeroderma pigmentosum complementation group D referred to · inactive
- ORPHA:276261OBSOLETE: Xeroderma pigmentosum complementation group E referred to · inactive
- ORPHA:276264OBSOLETE: Xeroderma pigmentosum complementation group F referred to · inactive
- ORPHA:276267OBSOLETE: Xeroderma pigmentosum complementation group G referred to · inactive
Genes
7 direct| Gene | Association | Status | HGNC | Ensembl | OMIM | Locus | Name | Source of validation |
|---|---|---|---|---|---|---|---|---|
| DDB2 | Disease-causing germline mutation(s) in | Assessed | HGNC:2718 | ENSG00000134574 | 600811 | 11p11.2 | damage specific DNA binding protein 2 | 20301571[PMID] |
| ERCC2 | Disease-causing germline mutation(s) in | Assessed | HGNC:3434 | ENSG00000104884 | 126340 | 19q13.32 | ERCC excision repair 2, TFIIH core complex helicase subunit | 20301571[PMID] |
| ERCC3 | Disease-causing germline mutation(s) in | Assessed | HGNC:3435 | ENSG00000163161 | 133510 | 2q14.3 | ERCC excision repair 3, TFIIH core complex helicase subunit | 20301571[PMID] |
| ERCC4 | Disease-causing germline mutation(s) in | Assessed | HGNC:3436 | ENSG00000175595 | 133520 | 16p13.12 | ERCC excision repair 4, endonuclease catalytic subunit | 20301571[PMID] |
| ERCC5 | Disease-causing germline mutation(s) in | Assessed | HGNC:3437 | ENSG00000134899 | 133530 | 13q33.1 | ERCC excision repair 5, endonuclease | 20301571[PMID] |
| XPA | Disease-causing germline mutation(s) in | Assessed | HGNC:12814 | ENSG00000136936 | 611153 | 9q22.33 | XPA, DNA damage recognition and repair factor | 20301571[PMID] |
| XPC | Disease-causing germline mutation(s) in | Assessed | HGNC:12816 | ENSG00000154767 | 613208 | 3p25.1 | XPC complex subunit, DNA damage recognition and repair factor | 20301571[PMID] |
Prevalence and incidence
9 records| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Point prevalence | 1-9 / 1 000 000 | 0.1 / 100 000 | United States | Value and class | Validated | [EXPERT] |
| Point prevalence | 1-9 / 100 000 | 4.5 / 100 000 | Japan | Value and class | Validated | 16905156[PMID] |
| Prevalence at birth | 1-9 / 1 000 000 | 0.23 / 100 000 | Europe | Value and class | Not yet validated | 18329345[PMID] |
| Prevalence at birth | 1-9 / 1 000 000 | 0.19 / 100 000 | United Kingdom | Value and class | Validated | 18329345[PMID] |
| Prevalence at birth | 1-9 / 1 000 000 | 0.41 / 100 000 | Netherlands | Value and class | Validated | 18329345[PMID] |
| Prevalence at birth | 1-9 / 1 000 000 | 0.16 / 100 000 | Italy | Value and class | Validated | 18329345[PMID] |
| Prevalence at birth | 1-9 / 1 000 000 | 0.34 / 100 000 | France | Value and class | Validated | 18329345[PMID] |
| Prevalence at birth | 1-9 / 1 000 000 | 0.18 / 100 000 | Germany | Value and class | Validated | 18329345[PMID] |
| Annual incidence | 1-9 / 100 000 | 1.75 / 100 000 | Libyan Arab Jamahiriya | Value and class | Not yet validated | 10440281[PMID] |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
HPO phenotypes
59 annotations · validated 2016-06-01| HPO | Term (as annotated by Orphanet) | Diagnostic |
|---|---|---|
| Very frequent (99-80%) | ||
| HP:0000164 | Abnormality of the dentition | |
| HP:0002829 | Arthralgia | |
| HP:0100543 | Cognitive impairment | |
| HP:0000524 | Conjunctival telangiectasia | |
| HP:0000992 | Cutaneous photosensitivity | |
| HP:0002376 | Developmental regression | |
| HP:0000958 | Dry skin | |
| HP:0002353 | EEG abnormality | |
| HP:0001508 | Failure to thrive | |
| HP:0012378 | Fatigue | |
| HP:0001945 | Fever | |
| HP:0001480 | Freckling | |
| HP:0000135 | Hypogonadism | |
| HP:0006887 | Intellectual disability, progressive | |
| HP:0000648 | Optic atrophy | |
| HP:0001029 | Poikiloderma | |
| HP:0001009 | Telangiectasia | |
| HP:0100585 | Telangiectasia of the skin | |
| HP:0001072 | Thickened skin | |
| HP:0000963 | Thin skin | |
| Frequent (79-30%) | ||
| HP:0000518 | Cataract | |
| HP:0000028 | Cryptorchidism | |
| HP:0004334 | Dermal atrophy | |
| HP:0010783 | Erythema | |
| HP:0000962 | Hyperkeratosis | |
| HP:0001034 | Hypermelanotic macule | |
| HP:0001053 | Hypopigmented skin patches | |
| HP:0000491 | Keratitis | |
| HP:0012733 | Macule | |
| HP:0002861 | Melanoma | |
| HP:0012740 | Papilloma | |
| HP:0000407 | Sensorineural hearing impairment | |
| HP:0000486 | Strabismus | |
| Occasional (29-5%) | ||
| HP:0002071 | Abnormality of extrapyramidal motor function | |
| HP:0001596 | Alopecia | |
| HP:0003355 | Aminoaciduria | |
| HP:0009755 | Ankyloblepharon | |
| HP:0001251 | Ataxia | |
| HP:0000498 | Blepharitis | |
| HP:0002120 | Cerebral cortical atrophy | |
| HP:0004493 | Craniofacial hyperostosis | |
| HP:0008734 | Decreased testicular size | |
| HP:0002750 | Delayed skeletal maturation | |
| HP:0000656 | Ectropion | |
| HP:0000621 | Entropion | |
| HP:0010649 | Flat nasal alae | |
| HP:0000365 | Hearing impairment | |
| HP:0000995 | Melanocytic nevus | |
| HP:0000252 | Microcephaly | |
| HP:0002664 | Neoplasm | |
| HP:0100012 | Neoplasm of the eye | |
| HP:0007759 | Opacification of the corneal stroma | |
| HP:0009830 | Peripheral neuropathy | |
| HP:0000613 | Photophobia | |
| HP:0001059 | Pterygium | |
| HP:0001315 | Reduced tendon reflexes | |
| HP:0001250 | Seizure | |
| HP:0004322 | Short stature | |
| HP:0001257 | Spasticity | |
Run the differential on the 12 obligate / very frequent terms
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/910
- This record as JSON: /data/d/910.json